SOURCE: ICAP Patent Brokerage

ICAP Patent Brokerage

November 19, 2015 15:08 ET

Intraluminal Ultrasound Catheter Patents Available from ICAP Patent Brokerage

ICAP Patent Brokerage Announces for Sale Patents Disclosing the Next Generation in Intravascular Ultrasound -- A Real-time 3-D Ultrasonic Intravascular Catheter; This Portfolio Is Available From Jay Lenker as Part of the Cardiovascular Patent Auction

NEW YORK, NY--(Marketwired - November 19, 2015) - ICAP Patent Brokerage announces for sale patents disclosing the next generation in intravascular ultrasound -- a real-time 3-D ultrasonic intravascular catheter. This portfolio is available from Jay Lenker as part of ICAP Patent Brokerage's December 2015 Cardiovascular Patent Auction.

The live virtual auction will opening for bidding on Tuesday, December 8th at 9 am PST and will have a bidding deadline of December 10th at 5 pm PST. The auction is a sealed bid format, and the highest value bids above reserve price will win each respective technology for sale.

Jay Lenker, Ph.D., is Co-Founder, President and CEO of Indian Wells Medical, Inc. and Damage Control Surgical Technologies, Inc. Dr. Lenker consulted and served as VP of Scientific Affairs for MicroVention, Inc., a startup company developing products for the treatment of cerebrovascular aneurysms. He has consulted and helped lead many startup companies in various capacities. See the inventor biography for Dr. Lenker.

"Dr. Lenker is an experienced, level-headed entrepreneur in the cardiovascular medical space," says Dean Becker, CEO of ICAP Patent Brokerage. "His 3D ultrasound catheter is an important and elegant solution for company interested in intravascular ultrasound, atherosclerosis, endoscopy, and angiography."

Key Characteristics & Benefits

Interventional cardiologists and radiologists will benefit from the real-time 3-D ultrasound guidance and visualization through body lumens using this patented technology. Visualization may be provided, for example, of the Fossa Ovalis, mitral valve, aortic valve, stenosis and the like. The market size for ultrasound for interventional procedures likely approaches $500MM for similar devices.

See the technical description of the Intraluminal Ultrasound Catheter IP sales offering.

Sample forward or rearward citing companies include Boston Scientific Corporation, Koninklijke Philips Nv, Medtronic Plc, Alcatel-lucent.

To learn more about the intellectual property available for sale in this portfolio:
Contact Michelle Tyler of ICAP Patent Brokerage at (312) 327-4438 or via email at michelle(at)icapip(dot)com.

If you would like to sell or auction a patent portfolio, visit our website to make a patent portfolio submission:
http://icappatentbrokerage.com/auction/submitip/

Follow us on Twitter (@ICAP_IP) and join our LinkedIn group.

About ICAP Patent Brokerage
ICAP Patent Brokerage is the world's largest intellectual property brokerage and patent auction firm, leveraging the talents of experienced patent brokers to match buyers and sellers for the sale of patents and other intellectual property assets. With multiple transaction platforms and unparalleled industry knowledge, including experience with trademarks, brands, intellectual property licensing, and UCC sales, ICAP Patent Brokerage is the global leader in the transaction of intellectual property.

Image Available: http://www.marketwire.com/library/MwGo/2015/11/19/11G072870/Images/cardio-Ad_11-16-15-3fdf36fc0d6dab4a97d317991b993e52.jpg

Contact Information

  • Sarah Saites
    (312) 327-4437
    Sarah(at)icapip(dot)com